Pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (AS1404), a novel vascular disrupting agent, in phase I clinical trial

✍ Scribed by M. B. Jameson; B. C. Baguley; P. Kestell; L. Zhao; J. W. Paxton; P. I. Thompson; S. Waller; on behalf of the Cancer Research (UK) Phase I/II Trials Committee

• Publisher: Springer
• Year: 2006
• Tongue: English
• Weight: 336 KB
• Volume: 59
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-006-0322-6